AI-Mind continues successful enrolment in its clinical study and its follow-up visits
The members of the AI-Mind consortium are glad to announce that its study is approaching its enrolment goals, with over three-quarters of recruited participants.
The AI-Mind research study is at the heart of the project and will help collecting invaluable data to develop and validate artificial intelligence (AI)-based tools to predict, at an early stage, who is likely to develop dementia. The AI-Mind study, launched in January 2022, is the largest European study of this kind and is aiming to recruit 1,000 participants across four countries in Norway, Finland, Italy and Spain. Almost 900 research participants have been enrolled so far. Participants, aged between 60 and 80 years, who either have a diagnosis of Mild Cognitive Impairment (MCI) or who are experiencing memory and concentration problems, are asked to visit the clinical sites for four appointments over two years, resulting in an appointment every eight months.
Project partners are pleased to share that the first participants enrolled in the study get back to their study site for their second or third visit. This milestone is a significant accomplishment for the study team, who expressed gratitude to all those who joined them. Their participation in the project involve standardised assessments including a short interview, digital cognitive tests (i.e. memory, thinking, language) and a procedure to measure electrical activity in the brain (EEG and MEG tests).
If you are interested to learn more about the study, please visit the dedicated sections on the AI-Mind website with new visualisations, as well as watch the explanatory video developed to inform potential participants about the AI-Mind study procedures.
You can also subscribe to the new quarterly study newsletter here to stay informed. By subscribing, you’ll gain a deeper understanding of the project’s progress and its potential impact on dementia research.